EMBCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Embecta Corp.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$6.21−0.06 (-0.96%)
Close on Oct 19, 2026
- Market cap
- $363.36M
- P/E (TTM)
- 4.2
- Dividend yield
- 9.66%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
88.9%
50M of 57M shares
Institutional holders
320
64 new, 72 sold out
Net institutional buying
-10M
In Q2 2026
Insider trades, 12 months
4 buys · 1 sales
Net bought $520.85K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 4,554,394 | 7.70% | 13G (passive) amendment | Jun 30, 2026 |
| Yacktman Asset Management LP | 3,671,877 | 6.20% | 13G (passive) | Mar 31, 2026 |
| Stowers Institute for Medical Research | 3,439,512 | 5.80% | 13G (passive) amendment | Mar 31, 2026 |
| Vanguard Capital Management | 3,004,501 | 5.07% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of EMBC | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4,599,771 | 8.12% | $15.00M | −4,567,441 | 0.00% |
| Yacktman Asset Management LP | 4,315,952 | 7.62% | $14.07M | +644,075 | 0.17% |
| Vanguard Capital Management LLC | 2,557,148 | 4.51% | $8.34M | −6,803 | 0.00% |
| Deerfield Management Company, L.P. (Series C) | 2,534,961 | 4.47% | $8.26M | – | 0.09% |
| Jefferies Financial Group Inc. | 2,355,117 | 4.16% | $7.68M | −45 | 0.05% |
| Ameriprise Financial Inc | 2,038,731 | 3.60% | $6.65M | +1,239,043 | 0.00% |
| Morgan Stanley | 1,996,747 | 3.52% | $6.51M | +1,386,943 | 0.00% |
| State Street Corp | 1,610,666 | 2.84% | $5.25M | −935,307 | 0.00% |
| Geode Capital Management, LLC | 1,594,457 | 2.81% | $5.20M | +128,810 | 0.00% |
| Brigade Capital Management, LP | 1,516,453 | 2.68% | $4.94M | New | 0.93% |
| Goldman Sachs Group Inc | 1,162,041 | 2.05% | $3.79M | +413,586 | 0.00% |
| Krensavage Asset Management, LLC | 1,135,340 | 2.00% | $3.70K | +400,000 | 1.41% |
| Vanguard Portfolio Management LLC | 1,098,389 | 1.94% | $3.58M | −439,568 | 0.00% |
| Charles Schwab Investment Management Inc | 1,069,786 | 1.89% | $3.49M | −122,247 | 0.00% |
| Jacobs Levy Equity Management, Inc | 1,027,514 | 1.81% | $3.35M | New | 0.01% |
| Aqr Capital Management LLC | 976,587 | 1.72% | $3.17M | +644,984 | 0.00% |
| Millennium Management LLC | 945,968 | 1.67% | $3.08M | −648,177 | 0.00% |
| Acadian Asset Management LLC | 861,281 | 1.52% | $2.80K | +561,078 | 0.00% |
| UBS Group AG | 829,099 | 1.46% | $2.70M | +399,049 | 0.00% |
| D. E. Shaw & Co., Inc. | 650,070 | 1.15% | $2.12M | +117,742 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 320 | 50M | 88.9% | 64 / 80 | 75 / 72 | 15M | 25M |
| Q1 2026 | 339 | 61M | 100.0% | 41 / 92 | 94 / 57 | 14M | 7M |
| Q4 2025 | 363 | 58M | 100.0% | 53 / 98 | 97 / 37 | 6M | 4M |
| Q3 2025 | 353 | 57M | 99.9% | 50 / 68 | 118 / 54 | 5M | 6M |
| Q2 2025 | 359 | 58M | 100.0% | 49 / 83 | 110 / 53 | 8M | 7M |
| Q1 2025 | 367 | 57M | 100.0% | 43 / 84 | 108 / 40 | 7M | 5M |
| Q4 2024 | 367 | 55M | 97.9% | 46 / 73 | 114 / 42 | 5M | 4M |
| Q3 2024 | 366 | 55M | 96.8% | 53 / 59 | 126 / 43 | 13M | 5M |
| Q2 2024 | 361 | 56M | 99.1% | 48 / 93 | 106 / 50 | 4M | 5M |
| Q1 2024 | 371 | 57M | 100.0% | 39 / 78 | 136 / 38 | 4M | 4M |
| Q4 2023 | 374 | 56M | 99.6% | 50 / 81 | 124 / 45 | 7M | 7M |
| Q3 2023 | 373 | 57M | 99.8% | 32 / 84 | 139 / 52 | 12M | 10M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of EMBC | Value | % of fund | As of |
|---|---|---|---|---|---|
| AMG Yacktman Fund | 3,500,000 | 6.18% | $11.41M | 0.16% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 1,831,834 | 3.23% | $5.97M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 1,633,537 | 2.88% | $5.33M | 0.01% | Jun 30, 2026 |
| Columbia Small Cap Value Discovery Fund | 1,362,130 | 2.40% | $4.96M | 0.20% | Jul 31, 2026 |
| Fidelity Small Cap Index Fund | 684,471 | 1.21% | $2.49M | 0.01% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 668,682 | 1.18% | $2.18M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 Value ETF | 539,388 | 0.95% | $1.76M | 0.01% | Jun 30, 2026 |
| Schwab Fundamental U.S. Small Company ETF | 457,597 | 0.81% | $1.55M | 0.02% | May 31, 2026 |
| PIMCO RAE US Small Fund | 342,162 | 0.60% | $1.12M | 0.03% | Jun 30, 2026 |
| Vanguard Russell 2000 Index Fund | 305,199 | 0.54% | $1.03M | 0.01% | May 31, 2026 |
| Fidelity Extended Market Index Fund | 303,260 | 0.54% | $1.03M | 0.00% | May 31, 2026 |
| Vanguard U.S. Value Factor ETF | 293,504 | 0.52% | $992.04K | 0.12% | May 31, 2026 |
| Schwab U.S. Small-Cap ETF | 279,317 | 0.49% | $944.09K | 0.00% | May 31, 2026 |
| WisdomTree U.S. SmallCap Dividend Fund | 259,196 | 0.46% | $844.98K | 0.04% | Jun 30, 2026 |
| Columbia Variable Portfolio - Small Cap Value Discovery Fund | 246,450 | 0.43% | $803.43K | 0.18% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Devdatt Kurdikar | President and CEO, Director | 804,919 | 1.42% | Aug 13, 2026 |
| Jeffrey Z. Mann | Pres, Pharm Svc&Prod Mgmt, CLO | 262,915 | 0.46% | Aug 13, 2026 |
| Jacob Elguicze | SVP and CFO | 309,139 | 0.55% | Aug 13, 2026 |
| Jean Casner | Chief Human Resources Officer | 85,915 | 0.15% | Aug 11, 2026 |
| Anthony M. Roth | VP, Chief Accounting Officer | 78,833 | 0.14% | Jun 2, 2026 |
| Shaun Curtis | SVP, Global Manuf./Sup. Chain | 95,324 | 0.17% | Dec 1, 2025 |
| Milton Mayo Morris | Director | 53,828 | 0.10% | Sep 8, 2026 |
| Robert J. Hombach | Director | 109,587 | 0.19% | Aug 13, 2026 |
| Christopher R. Reidy | Director | 70,122 | 0.12% | Feb 13, 2026 |
| Karen Prange | Director | 64,581 | 0.11% | Feb 13, 2026 |
| Carrie L. Anderson | Director | 64,581 | 0.11% | Feb 13, 2026 |
| Claire Pomeroy | Director | 66,127 | 0.12% | Feb 13, 2026 |
| David F. Melcher | Director | 86,681 | 0.15% | May 23, 2025 |
| David Albritton | Director | 39,743 | 0.07% | Feb 14, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Milton Mayo Morris Director | Sep 4, 2026 | Sale | −6,293 | $5.88 | $37.00K | 53,828 |
| Robert J. Hombach Director | Aug 12, 2026 | Buy | +45,000 | $4.97 | $223.65K | 109,587 |
| Jacob Elguicze SVP and CFO | Aug 12, 2026 | Buy | +20,000 | $4.67 | $93.40K | 309,139 |
| Jeffrey Z. Mann Pres, Pharm Svc&Prod Mgmt, CLO | Aug 12, 2026 | Buy | +20,000 | $4.99 | $99.80K | 262,915 |
| Devdatt Kurdikar President and CEO, Director | Aug 12, 2026 | Buy | +30,000 | $4.70 | $141.00K | 804,919 |
| Jean Casner Chief Human Resources Officer | Aug 9, 2026 | Tax withholding | −1,480 | $4.42 | $6.54K | 85,915 |
| Anthony M. Roth VP, Chief Accounting Officer | Jun 1, 2026 | Award | +30,000 | – | – | 78,833 |
| Milton Mayo Morris Director | Feb 11, 2026 | Award | +22,841 | – | – | 60,121 |
| Carrie L. Anderson Director | Feb 11, 2026 | Award | +22,841 | – | – | 64,581 |
| Christopher R. Reidy Director | Feb 11, 2026 | Award | +22,841 | – | – | 70,122 |
| Claire Pomeroy Director | Feb 11, 2026 | Award | +22,841 | – | – | 66,127 |
| Robert J. Hombach Director | Feb 11, 2026 | Award | +22,841 | – | – | 64,587 |
| Karen Prange Director | Feb 11, 2026 | Award | +22,841 | – | – | 64,581 |
| Devdatt Kurdikar President and CEO, Director | Nov 26, 2025 | Tax withholding | −128,630 | $12.57 | $1.62M | 774,919 |
| Devdatt Kurdikar President and CEO, Director | Nov 26, 2025 | Award | +103,626 | – | – | 903,549 |
| Devdatt Kurdikar President and CEO, Director | Nov 26, 2025 | Award | +288,386 | – | – | 799,923 |
| Jacob Elguicze SVP and CFO | Nov 26, 2025 | Award | +95,466 | – | – | 267,863 |
| Jacob Elguicze SVP and CFO | Nov 26, 2025 | Award | +30,147 | – | – | 298,010 |
| Jacob Elguicze SVP and CFO | Nov 26, 2025 | Tax withholding | −24,782 | $12.57 | $311.51K | 273,228 |
| Anthony M. Roth Chief Accounting Officer | Nov 26, 2025 | Award | +32,817 | – | – | 49,296 |
| Anthony M. Roth Chief Accounting Officer | Nov 26, 2025 | Tax withholding | −1,881 | $12.57 | $23.64K | 47,415 |
| Jeffrey Z. Mann SVP, GC, Head Corp. Dev., Secy | Nov 26, 2025 | Tax withholding | −19,605 | $12.57 | $246.43K | 227,004 |
| Jeffrey Z. Mann SVP, GC, Head Corp. Dev., Secy | Nov 26, 2025 | Award | +79,555 | – | – | 222,114 |
| Jeffrey Z. Mann SVP, GC, Head Corp. Dev., Secy | Nov 26, 2025 | Award | +24,495 | – | – | 246,609 |
| Jean Casner Chief Human Resources Officer | Nov 26, 2025 | Award | +38,783 | – | – | 88,030 |
| Jean Casner Chief Human Resources Officer | Nov 26, 2025 | Tax withholding | −3,325 | $12.57 | $41.80K | 84,705 |
| Shaun Curtis SVP, Global Manuf./Sup. Chain | Nov 26, 2025 | Tax withholding | −15,380 | $12.57 | $193.33K | 95,324 |
| Shaun Curtis SVP, Global Manuf./Sup. Chain | Nov 26, 2025 | Award | +11,305 | – | – | 110,704 |
| Shaun Curtis SVP, Global Manuf./Sup. Chain | Nov 26, 2025 | Award | +37,789 | – | – | 99,399 |
| Jean Casner Chief Human Resources Officer | Aug 9, 2025 | Tax withholding | −916 | $12.28 | $11.25K | 48,799 |
| David F. Melcher Director | May 23, 2025 | Buy | +10,000 | $10.60 | $106.00K | 86,681 |
| Shaun Curtis SVP, Global Manuf./Sup. Chain | Apr 4, 2025 | Tax withholding | −3,249 | $12.00 | $38.99K | 59,061 |
| Devdatt Kurdikar President and CEO, Director | Apr 4, 2025 | Tax withholding | −39,592 | $12.00 | $475.10K | 499,582 |
| Jacob Elguicze SVP and CFO | Apr 4, 2025 | Tax withholding | −4,948 | $12.00 | $59.38K | 168,599 |
| Jeffrey Z. Mann SVP, GC, Head Corp. Dev., Secy | Apr 4, 2025 | Tax withholding | −5,285 | $12.00 | $63.42K | 139,439 |
| David F. Melcher Director | Feb 25, 2025 | Buy | +13,000 | $13.67 | $177.71K | 76,681 |
| Milton Mayo Morris Director | Feb 13, 2025 | Sale | −3,100 | $16.38 | $50.78K | 36,133 |
| Claire Pomeroy Director | Feb 12, 2025 | Award | +13,839 | – | – | 41,289 |
| Karen Prange Director | Feb 12, 2025 | Award | +13,839 | – | – | 39,743 |
| Carrie L. Anderson Director | Feb 12, 2025 | Award | +13,839 | – | – | 39,743 |
| Christopher R. Reidy Director | Feb 12, 2025 | Award | +13,839 | – | – | 45,284 |
| Milton Mayo Morris Director | Feb 12, 2025 | Award | +13,839 | – | – | 39,233 |
| Robert J. Hombach Director | Feb 12, 2025 | Award | +13,839 | – | – | 39,749 |
| David F. Melcher Director | Feb 12, 2025 | Award | +17,450 | – | – | 63,681 |
| David Albritton Director | Feb 12, 2025 | Award | +13,839 | – | – | 39,743 |
| Anthony M. Roth Chief Accounting Officer | Dec 2, 2024 | Award | +15,762 | – | – | 15,762 |
| Jeffrey Z. Mann SVP, GC, Head Corp. Dev., Secy | Nov 26, 2024 | Award | +50,803 | – | – | 150,584 |
| Jeffrey Z. Mann SVP, GC, Head Corp. Dev., Secy | Nov 26, 2024 | Tax withholding | −8,016 | $18.70 | $149.90K | 142,568 |
| Devdatt Kurdikar President and CEO, Director | Nov 26, 2024 | Tax withholding | −48,956 | $18.70 | $915.48K | 531,240 |
| Devdatt Kurdikar President and CEO, Director | Nov 26, 2024 | Award | +187,166 | – | – | 580,196 |
| Jean Casner Chief Human Resources Officer | Nov 26, 2024 | Tax withholding | −1,281 | $18.70 | $23.95K | 48,288 |
| Jean Casner Chief Human Resources Officer | Nov 26, 2024 | Award | +23,396 | – | – | 49,569 |
| Shaun Curtis SVP, Global Manuf./Sup. Chain | Nov 26, 2024 | Award | +24,065 | – | – | 67,194 |
| Shaun Curtis SVP, Global Manuf./Sup. Chain | Nov 26, 2024 | Tax withholding | −5,806 | $18.70 | $108.57K | 61,388 |
| Jacob Elguicze SVP and CFO | Nov 26, 2024 | Tax withholding | −9,785 | $18.70 | $182.98K | 170,882 |
| Jacob Elguicze SVP and CFO | Nov 26, 2024 | Award | +61,498 | – | – | 180,667 |
| Jean Casner Chief Human Resources Officer | Aug 9, 2024 | Tax withholding | −916 | $15.39 | $14.10K | 26,000 |
| Jacob Elguicze SVP and CFO | May 10, 2024 | Tax withholding | −1,013 | $14.24 | $14.43K | 117,633 |
| Devdatt Kurdikar President and CEO, Director | Apr 4, 2024 | Tax withholding | −4,535 | $12.78 | $57.96K | 388,005 |
| David F. Melcher Director | Feb 12, 2024 | Buy | +2,000 | $16.25 | $32.50K | 45,080 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Milton Mayo Morris Director | Sep 4, 2026 | 6,293 | $36.89K | Sep 4, 2026 | DIRECTORS COMPENSATION |
| Milton Mayo Morris Director | Feb 13, 2025 | 3,100 | $50.78K | Feb 13, 2025 | STOCK GRANT |